Report Categories
View AllRecent Articles
View All
ORMP Oramed Pharmaceuticals Inc rises 053 percent following release of its 2025 fourth quarter earnings results
Zhengye ZYBT Trading Strategy Zhengye Biotechnology posts 024 EPS 186M revenue no estimates
Clearwater CLW Stock Dark Pool Activity Technical Strength 20260418
The quality metrics hidden in Icahn IEP earnings Q4 2025 Profit Disappoints
Equity ELS Industry Outlook Q4 2025 Profit Surprises
RBC RBC Stock Is It a Smart Buy Trend Strengthens 20260418
ORKT Orangekloud Technology Inc shares rise 283 percent even as Q4 2024 losses far outpace analyst consensus forecasts
Is Hour Loop HOUR stock showing recovery signs Buying Pressure 20260418
Biofrontera BFRI Q1 2026 Earnings Miss EPS 037 vs 012 Expected
Indian Auto Exports Surge 38 as OEMs Tap Emerging Markets for Growth
Jim Cramer Says It Is a Bull Market for Eli Lilly Heres Why the Stock May Have Room to Run
NRX Pharmaceuticals NRXP Stock Analysis Climbs 187 Eyes on 343 20260515
Merchants MBINN Slides 062 as Selling Pressure Mounts 20260515
Aligos ALGS Delivers Q1 2026 Beat EPS 221 vs 227 Expected
Century Alum CENX Stock Analysis 752 Loss Key Levels 20260517
Avidbank AVBH Fell 102 Is a Recovery Ahead 20260515
Talphera Reports Q1 2026 Loss Raises Going Concern and Nasdaq Compliance Concerns
SpaceX PreIPO Investment Five Critical Questions to Ask Before Buying Exposure
Cruise Line Dining Wars How Viking and Royal Caribbean Are Transforming Onboard Revenue